Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick W Mallon

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The Lancet. HIV|November 2, 2015
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trialJose I Bernardino, Amanda Mocroft, Patrick W Mallon, et al.
Clinical and Translational Medicine|June 12, 2026
Refining inflammatory profiles linked to cardiometabolic outcomes in people with HIV using recursive feature addition modellingRachel MacCann, Dana Alalwan, Gurvin Saini, et al.
Journal of Thrombosis and Haemostasis : JTH|May 30, 2021
ADAMTS13 regulation of VWF multimer distribution in severe COVID-19Soracha E Ward, Helen Fogarty, Ellie Karampini, et al.
Microbes and Infection|November 9, 2023
Associations between host microbiome and inflammation suggest role for host microbiome in driving COVID-19 disease severityRachel MacCann, Tarini Shankar Ghosh, Alejandro Abner Garcia Leon, et al.
Research and Practice in Thrombosis and Haemostasis|February 23, 2023
Endothelial cell activation, Weibel-Palade body secretion, and enhanced angiogenesis in severe COVID-19Ellie Karampini, Helen Fogarty, Stephanie Elliott, et al.
Plos One|September 9, 2025
Protocol for a core outcome set for pharmacological treatments in hospitalised patients with acute viral respiratory infections (COSAVRI)Declan Devane, Matthias Briel, Sanjay Bhagani, et al.
British Journal of Haematology|December 16, 2020
Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activationSoracha E Ward, Gerard F Curley, Michelle Lavin, et al.
Journal of Thrombosis and Haemostasis : JTH|August 10, 2021
Persistent endotheliopathy in the pathogenesis of long COVID syndromeHelen Fogarty, Liam Townsend, Hannah Morrin, et al.
Journal of Thrombosis and Haemostasis : JTH|July 25, 2022
Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunctionHelen Fogarty, Soracha E Ward, Liam Townsend, et al.
Ebiomedicine|February 26, 2022
Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implicationsOisin F McElvaney, Takanori Asakura, Suzanne L Meinig, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Lancet. HIV|November 2, 2015
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trialJose I Bernardino, Amanda Mocroft, Patrick W Mallon, et al.
Clinical and Translational Medicine|June 12, 2026
Refining inflammatory profiles linked to cardiometabolic outcomes in people with HIV using recursive feature addition modellingRachel MacCann, Dana Alalwan, Gurvin Saini, et al.
Journal of Thrombosis and Haemostasis : JTH|May 30, 2021
ADAMTS13 regulation of VWF multimer distribution in severe COVID-19Soracha E Ward, Helen Fogarty, Ellie Karampini, et al.
Microbes and Infection|November 9, 2023
Associations between host microbiome and inflammation suggest role for host microbiome in driving COVID-19 disease severityRachel MacCann, Tarini Shankar Ghosh, Alejandro Abner Garcia Leon, et al.
Research and Practice in Thrombosis and Haemostasis|February 23, 2023
Endothelial cell activation, Weibel-Palade body secretion, and enhanced angiogenesis in severe COVID-19Ellie Karampini, Helen Fogarty, Stephanie Elliott, et al.
Plos One|September 9, 2025
Protocol for a core outcome set for pharmacological treatments in hospitalised patients with acute viral respiratory infections (COSAVRI)Declan Devane, Matthias Briel, Sanjay Bhagani, et al.
British Journal of Haematology|December 16, 2020
Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activationSoracha E Ward, Gerard F Curley, Michelle Lavin, et al.
Journal of Thrombosis and Haemostasis : JTH|August 10, 2021
Persistent endotheliopathy in the pathogenesis of long COVID syndromeHelen Fogarty, Liam Townsend, Hannah Morrin, et al.
Journal of Thrombosis and Haemostasis : JTH|July 25, 2022
Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunctionHelen Fogarty, Soracha E Ward, Liam Townsend, et al.
Ebiomedicine|February 26, 2022
Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implicationsOisin F McElvaney, Takanori Asakura, Suzanne L Meinig, et al.
Pageof 3